Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Pharmacy --- Pharmaceutical industry --- History. --- History.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"The proposed book will focus on practical issues in pharmaceutical/clinical research and development from both regulatory and scientific perspectives. The book will outline and clarify those issues that have been commonly misused in the subject area of regulatory science"--

Drugs --- Clinical trials --- Pharmacy --- Research --- Testing. --- Statistical methods. --- Research.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Im seit 1985 als Buch erscheinenden Arzneiverordnungs-Report werden die Rezepte für die Patienten der gesetzlichen Krankenversicherung (GKV) mit Methoden der evidenzbasierten Medizin analysiert. Seit dieser Zeit bietet der Report eine unabhängige Informationsmöglichkeit über die verschiedenen Komponenten der Arzneimittelverordnung und trägt damit zur Transparenz des Arzneimittelmarkts, zur Bewertung von Arzneimitteln und zu einer sowohl zweckmäßigen und sicheren evidenzbasierten als auch wirtschaftlichen Arzneitherapie bei. Aus dem Inhalt Allgemeine Verordnungs- und Marktentwicklung Indikationsgruppen Analysen von Arzt- und Patientengruppen sowie Regionen Anhang mit ergänzender statistischer Übersicht Die Herausgeber Professor em. Dr. med. Ulrich Schwabe, Pharmakologisches Institut der Universität Heidelberg Dr. rer. soc. Dieter Paffrath, Köln Professor Dr. med. Wolf-Dieter Ludwig, Arzneimittelkommission der deutschen Ärzteschaft, Berlin Jürgen Klauber, Wissenschaftliches Institut der AOK (WIdO), Berlin.

Internal medicine. --- Pharmacotherapy. --- Neurology . --- General practice (Medicine). --- Medical policy. --- Pharmacy. --- Internal Medicine. --- Pharmacotherapy. --- Neurology. --- General Practice / Family Medicine. --- Health Policy. --- Pharmacy.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"The book studies the pharmaceutical industry of India. It is one of the most successful stories of economic expansion and improvements in public health. Indian firms have made access to quality medicines possible and affordable in many developing countries. Indian pharmaceuticals are also exported on a large scale to the United States and other highly regulated markets. A wave of mergers, acquisitions and tie-ups point to growing integration between Indian firms and global pharma multinationals."--Provided by publisher.

Pharmaceutical policy --- Pharmacy --- Drug accessibility --- Drug accessibility. --- Law and legislation --- Law and legislation.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills.

Pharmaceutical industry --- Drugs --- Pharmaceutical policy. --- Drug policy --- Drugs and state --- Pharmacy --- Pharmacy and state --- State and drugs --- State and pharmacy --- Medical policy --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Drug industry --- Drug trade --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Economic aspects. --- Cost effectiveness. --- Government policy